9 August 2021 - Multiple sclerosis patients in England are paying £600 a month for a “life-changing drug” which is available on the NHS in Wales and Scotland.
Fampridine is part of a group of medicines known as potassium channel blockers, which helps people with MS to walk with more ease and lowers the risk of falling.